GNS Healthcare raises M for precision medicine analytics

Cambridge, Massachusetts-based GNS Healthcare, which has developed an analytics tool for precision medicine and population health, raised $10 million from Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund. Existing investors Cambia Health Solutions, Heritage Provider Network, and Mitsui USA, the US subsidiary of Japan’s Mitsui & Co, also participated. This brings the company’s total funding to at least $33 million. GNS has developed a machine learning and simulation platform, called REFS (Reverse Engineering and Forward Simulation), that collects patient data, including information from electronic medical records, connected health devices, medical and pharmacy claims, genomics, and consumer behavior. The company uses this data to identify what health interventions and drugs would be best suited for individual patients. This would in turn help healthcare organizations improve outcomes and lower costs related to preterm birth, medication…


Link to Full Article: GNS Healthcare raises M for precision medicine analytics